サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1799200

スマート埋め込み型ポンプの世界市場

Smart Implantable Pumps

出版日
ページ情報
英文 173 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.92円
スマート埋め込み型ポンプの世界市場
出版日: 2025年08月27日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 173 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

スマート埋め込み型ポンプの世界市場は2030年までに36億米ドルに達する

2024年に27億米ドルと推定されるスマート埋め込み型ポンプの世界市場は、2024年から2030年にかけてCAGR 5.3%で成長し、2030年には36億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるスマート灌流ポンプは、CAGR 4.2％を記録し、分析期間終了時には22億米ドルに達すると予測されます。スマートマイクロポンプセグメントの成長率は、分析期間でCAGR 7.2％と推定されます。

米国市場は6億9,760万米ドルと推定、中国はCAGR 5.3％で成長予測

米国のスマート埋め込み型ポンプ市場は、2024年には6億9,760万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを5.3%として、2030年までに5億8,590万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ4.8%と4.6%と予測されています。欧州では、ドイツがCAGR 4.4%で成長すると予測されています。

世界のスマート埋め込み型ポンプ市場- 主要動向と促進要因のまとめ

スマート埋め込み型ポンプは慢性疾患治療をどう変えるか？

スマート埋め込み型ポンプは、プログラム可能で正確な連続注入機能を提供することで、人体内への薬剤や治療薬の送達に革命をもたらしています。外部または手動の送達方法とは異なり、これらの小型で生体適合性のあるデバイスは、外科的に皮下または体腔内に設置され、最小限の患者の介入で、標的を絞った長期的な治療を保証します。疼痛、痙縮、糖尿病、がん、心血管疾患など、一貫した投与と生理学的フィードバックへの応答性が不可欠な慢性疾患の管理には不可欠です。

スマート埋め込み型ポンプと従来のシステムとの違いは、センサー、マイクロプロセッサー、ワイヤレステレメトリーとの統合により、リアルタイムの調整、データロギング、臨床医の監視が可能になったことです。患者はもはや厳格な投与スケジュールを守る必要はなく、従来の薬物レジメンのピークと谷に耐える必要もないです。その代わりに、これらのシステムは生物学的シグナルに基づいて投与量を漸増することができ、治療成績を向上させ、副作用を減らすことができます。また、頻繁な通院も不要となり、遠隔医療や個別化ヘルスケアの要となります。

次世代の埋め込み型デリバリー・システムを支える技術とは？

最新のスマートポンプは、微小電気機械システム（MEMS）、無線通信、低電力エレクトロニクス、生体適合性材料の融合です。MEMS技術は、機能を損なうことなく小型化を可能にし、ポンプを安全に移植し、低侵襲処置で再充填することを可能にします。一部のポンプは、注入精度をモニターし、閉塞を検出し、患者の生理学的変化に対応する圧力および流量センサーを備えています。

ワイヤレス遠隔測定により、ハンドヘルドプログラマーやBluetooth対応スマートフォンを介して、デバイスと外部リーダーまたは臨床医インターフェースとの双方向通信が可能になります。医師は、投与履歴、バッテリー寿命、機器の機能を遠隔でモニターし、リアルタイムで投与量の調整を行うこともできます。再充電可能なバッテリー、誘導充電技術、エネルギーハーベスティング機構により、機器の寿命が延び、外科的介入の回数が減っています。クラウドベースの健康プラットフォームとの統合により、臨床的意思決定支援のための長期的なデータ追跡が可能になります。

スマート埋め込み型ポンプはどこで最も臨床的インパクトを与えているか？

これらのデバイスは、腫瘍学において生命を変えるような利益をもたらしています。そこでは、化学治療薬の持続的注入によって、腫瘍の標的性を高めると同時に、全身毒性を軽減することができます。疼痛管理では、スマートポンプによる髄腔内ドラッグデリバリーは、オピオイドに代わる強力な選択肢となり、難治性疼痛患者の依存を最小限に抑え、QOLを向上させる。多発性硬化症や脳性麻痺などの痙縮に対しては、スマートバクロフェンポンプによって、正確で的を絞った神経調節が可能になります。

糖尿病治療では、外付けのインスリンポンプが主流だが、特に持続グルコースモニター（CGM）と組み合わせた長期的なグルコース管理のために、埋め込み型が台頭してきています。心臓病学はもうひとつの成長分野であり、抗凝固剤、抗高血圧剤、抗不整脈剤の制御送達を目的としたスマートポンプの開発が進められています。さらに、パーキンソン病やアルツハイマー病などの神経変性疾患では、植え込み型注入システムによる治療薬の標的頭蓋内投与が検討されています。

スマート埋め込み型ポンプ市場の成長はいくつかの要因によって牽引されている...

継続的な治療や高度な標的治療を必要とする慢性疾患や生活習慣病の世界の増加により、市場は急速に拡大しています。小型化、電力管理、テレメトリー、薬物リザーバー材料などの技術進歩により、デバイスの寿命、安全性、応答性が向上しています。遠隔患者モニタリング、病院-在宅ケアモデル、個別化された治療プロトコルに対する需要の高まりが、スマートで自律的な送達システムの魅力を高めています。

さらに、有利な保険償還の枠組み、デジタル治療薬に対する規制当局の支援、植込み型機器に対する臨床医の習熟度の高まりが、導入障壁を低くしています。医療技術企業、デジタルヘルスプラットフォーム、製薬企業間のコラボレーションも、ポンプを利用したドラッグデリバリーモデルのイノベーションを促進しています。ヘルスケアシステムが患者のアドヒアランス、アウトカムベースのケア、費用対効果の高い慢性疾患管理を優先させる中、スマート埋め込み型ポンプは次世代治療薬の基盤要素になる準備が整っています。

セグメント

ポンプタイプ（スマート灌流ポンプ、スマートマイクロポンプ）、用途（疼痛用途、痙縮用途、心臓血管用途、その他用途）、最終用途（病院最終用途、外来手術センター最終用途、その他最終用途）

調査対象企業の例

  • Abbott Laboratories
  • Abiomed（Johnson & Johnson）
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Berlin Heart GmbH
  • Boston Scientific Corporation
  • Cognos Therapeutics, Inc.
  • Debiotech SA
  • D. Medical Industries Ltd.
  • Flowonix Medical Inc.
  • Fresenius Kabi AG
  • Insulet Corporation
  • Intarcia Therapeutics, Inc.
  • Johnson & Johnson（other implants）
  • Medtronic plc
  • MPS Microsystems
  • Q-Core Medical Ltd.
  • Smiths Medical
  • Terumo Corporation
  • Tricumed Medizintechnik GmbH
  • Tandem Diabetes Care, Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP39353

Global Smart Implantable Pumps Market to Reach US$3.6 Billion by 2030

The global market for Smart Implantable Pumps estimated at US$2.7 Billion in the year 2024, is expected to reach US$3.6 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2024-2030. Smart Perfusion Pumps, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$2.2 Billion by the end of the analysis period. Growth in the Smart Micro Pumps segment is estimated at 7.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$697.6 Million While China is Forecast to Grow at 5.3% CAGR

The Smart Implantable Pumps market in the U.S. is estimated at US$697.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$585.9 Million by the year 2030 trailing a CAGR of 5.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.8% and 4.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Global Smart Implantable Pumps Market - Key Trends & Drivers Summarized

How Are Smart Implantable Pumps Transforming Chronic Disease Therapy?

Smart implantable pumps are revolutionizing the delivery of medications and therapeutic agents within the human body by providing programmable, precise, and continuous infusion capabilities. Unlike external or manual delivery methods, these miniature, biocompatible devices are surgically placed under the skin or within body cavities to ensure targeted, long-term treatment with minimal patient intervention. They are critical for managing chronic conditions such as pain, spasticity, diabetes, cancer, and cardiovascular diseases, where consistent dosing and responsiveness to physiological feedback are essential.

What differentiates smart implantable pumps from legacy systems is their integration with sensors, microprocessors, and wireless telemetry, enabling real-time adjustments, data logging, and clinician oversight. Patients no longer need to adhere to strict dosing schedules or tolerate the peaks and troughs of conventional drug regimens. Instead, these systems can titrate doses based on biological signals, improving therapeutic outcomes and reducing side effects. They also eliminate the need for frequent hospital visits, making them a linchpin of remote and personalized healthcare.

What Technologies Are Powering Next-Generation Implantable Delivery Systems?

The modern smart pump is a convergence of microelectromechanical systems (MEMS), wireless communication, low-power electronics, and biocompatible materials. MEMS technology enables miniaturization without compromising functionality, allowing pumps to be safely implanted and refilled through minimally invasive procedures. Some pumps are equipped with pressure and flow sensors that monitor infusion accuracy, detect occlusions, or adjust for changes in patient physiology.

Wireless telemetry allows two-way communication between the device and external readers or clinician interfaces, often via handheld programmers or Bluetooth-enabled smartphones. Physicians can remotely monitor dosage history, battery life, and device function-and even make dosing adjustments in real time. Rechargeable batteries, inductive charging technologies, and energy harvesting mechanisms are enabling longer device lifespans and fewer surgical interventions. Integration with cloud-based health platforms allows longitudinal data tracking for clinical decision support.

Where Are Smart Implantable Pumps Making the Most Clinical Impact?

These devices are delivering life-changing benefits in oncology, where continuous infusion of chemotherapeutics can increase tumor targeting while reducing systemic toxicity. In pain management, intrathecal drug delivery via smart pumps offers a powerful alternative to opioids, minimizing dependence and improving quality of life for patients with intractable pain. For spasticity in conditions like multiple sclerosis and cerebral palsy, smart baclofen pumps allow precise, targeted neuromodulation.

In diabetes care, while external insulin pumps dominate, implantable versions are gaining ground for long-term glucose management, especially when coupled with continuous glucose monitors (CGMs). Cardiology is another growing frontier, with smart pumps under development for the controlled delivery of anticoagulants, antihypertensives, and anti-arrhythmic agents. Additionally, investigational applications in neurodegenerative disorders, such as Parkinson’s and Alzheimer’s disease, involve targeted intracranial delivery of therapeutics via implantable infusion systems.

The Growth in the Smart Implantable Pumps Market Is Driven by Several Factors…

The market is expanding rapidly due to rising global prevalence of chronic and lifestyle-related diseases requiring continuous or highly targeted therapy. Technological advancements in miniaturization, power management, telemetry, and drug reservoir materials are enhancing device longevity, safety, and responsiveness. Increasing demand for remote patient monitoring, hospital-at-home care models, and personalized treatment protocols is reinforcing the appeal of smart, autonomous delivery systems.

Furthermore, favorable reimbursement frameworks, regulatory support for digital therapeutics, and growing clinician familiarity with implantable devices are reducing adoption barriers. Collaborations between medtech firms, digital health platforms, and pharmaceutical companies are also fostering innovation in pump-enabled drug delivery models. As healthcare systems prioritize patient adherence, outcome-based care, and cost-effective chronic disease management, smart implantable pumps are poised to become a foundational element of next-generation therapeutics.

SCOPE OF STUDY:

The report analyzes the Smart Implantable Pumps market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Pump Type (Smart Perfusion Pumps, Smart Micro Pumps); Application (Pain Application, Spasticity Application, Cardiovascular Application, Other Applications); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 41 Featured) -

  • Abbott Laboratories
  • Abiomed (Johnson & Johnson)
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Berlin Heart GmbH
  • Boston Scientific Corporation
  • Cognos Therapeutics, Inc.
  • Debiotech SA
  • D. Medical Industries Ltd.
  • Flowonix Medical Inc.
  • Fresenius Kabi AG
  • Insulet Corporation
  • Intarcia Therapeutics, Inc.
  • Johnson & Johnson (other implants)
  • Medtronic plc
  • MPS Microsystems
  • Q-Core Medical Ltd.
  • Smiths Medical
  • Terumo Corporation
  • Tricumed Medizintechnik GmbH
  • Tandem Diabetes Care, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Smart Implantable Pumps - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rise in Chronic Disease Management Needs Propels Demand for Implantable Drug Delivery Devices
    • Miniaturization and Biocompatibility Advancements Drive Adoption of Smart Implantable Pumps
    • Integration with Remote Monitoring Platforms Strengthens Case for Connected Drug Delivery Systems
    • Increased Use of Closed-Loop Systems in Diabetes Management Expands Addressable Market
    • Clinical Shift Toward Targeted and Personalized Therapies Spurs Smart Pump Innovation
    • Surge in Demand for Pain Management Solutions Drives Interest in Programmable Intrathecal Pumps
    • Expansion of Wearables and Implantables Ecosystems Supports Smart Pump Interoperability
    • Real-Time Data Feedback Loops Enable Adaptive Dosing and Improved Patient Outcomes
    • Improved Battery Life and Wireless Charging Capabilities Enhance Patient Comfort and Compliance
    • Remote Software Updates and Physician Control Platforms Drive Clinical Utility
    • Growth of Home-Based Infusion Therapy Creates Demand for Safe, Long-Term Implantable Delivery
    • Regulatory Support for Digital Therapeutics Encourages Smart Pump Innovation in Niche Therapies
    • Collaborations Between MedTech and Biopharma Firms Fuel Innovation in Combination Delivery Systems
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Smart Implantable Pumps Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Smart Implantable Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Smart Implantable Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Smart Perfusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Smart Perfusion Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Smart Micro Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Smart Micro Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Pain Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Pain Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Spasticity Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Spasticity Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Cardiovascular Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Cardiovascular Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Smart Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 22: USA Recent Past, Current & Future Analysis for Smart Implantable Pumps by Pump Type - Smart Perfusion Pumps and Smart Micro Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 23: USA 6-Year Perspective for Smart Implantable Pumps by Pump Type - Percentage Breakdown of Value Sales for Smart Perfusion Pumps and Smart Micro Pumps for the Years 2025 & 2030
    • TABLE 24: USA Recent Past, Current & Future Analysis for Smart Implantable Pumps by Application - Pain Application, Spasticity Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 25: USA 6-Year Perspective for Smart Implantable Pumps by Application - Percentage Breakdown of Value Sales for Pain Application, Spasticity Application, Cardiovascular Application and Other Applications for the Years 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Smart Implantable Pumps by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for Smart Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • CANADA
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Smart Implantable Pumps by Pump Type - Smart Perfusion Pumps and Smart Micro Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Canada 6-Year Perspective for Smart Implantable Pumps by Pump Type - Percentage Breakdown of Value Sales for Smart Perfusion Pumps and Smart Micro Pumps for the Years 2025 & 2030
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Smart Implantable Pumps by Application - Pain Application, Spasticity Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Canada 6-Year Perspective for Smart Implantable Pumps by Application - Percentage Breakdown of Value Sales for Pain Application, Spasticity Application, Cardiovascular Application and Other Applications for the Years 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Smart Implantable Pumps by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada 6-Year Perspective for Smart Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • JAPAN
    • Smart Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Smart Implantable Pumps by Pump Type - Smart Perfusion Pumps and Smart Micro Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Japan 6-Year Perspective for Smart Implantable Pumps by Pump Type - Percentage Breakdown of Value Sales for Smart Perfusion Pumps and Smart Micro Pumps for the Years 2025 & 2030
    • TABLE 36: Japan Recent Past, Current & Future Analysis for Smart Implantable Pumps by Application - Pain Application, Spasticity Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Japan 6-Year Perspective for Smart Implantable Pumps by Application - Percentage Breakdown of Value Sales for Pain Application, Spasticity Application, Cardiovascular Application and Other Applications for the Years 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Smart Implantable Pumps by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan 6-Year Perspective for Smart Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • CHINA
    • Smart Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 40: China Recent Past, Current & Future Analysis for Smart Implantable Pumps by Pump Type - Smart Perfusion Pumps and Smart Micro Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: China 6-Year Perspective for Smart Implantable Pumps by Pump Type - Percentage Breakdown of Value Sales for Smart Perfusion Pumps and Smart Micro Pumps for the Years 2025 & 2030
    • TABLE 42: China Recent Past, Current & Future Analysis for Smart Implantable Pumps by Application - Pain Application, Spasticity Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: China 6-Year Perspective for Smart Implantable Pumps by Application - Percentage Breakdown of Value Sales for Pain Application, Spasticity Application, Cardiovascular Application and Other Applications for the Years 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Smart Implantable Pumps by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China 6-Year Perspective for Smart Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • EUROPE
    • Smart Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Smart Implantable Pumps by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 47: Europe 6-Year Perspective for Smart Implantable Pumps by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Smart Implantable Pumps by Pump Type - Smart Perfusion Pumps and Smart Micro Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Europe 6-Year Perspective for Smart Implantable Pumps by Pump Type - Percentage Breakdown of Value Sales for Smart Perfusion Pumps and Smart Micro Pumps for the Years 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Smart Implantable Pumps by Application - Pain Application, Spasticity Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Smart Implantable Pumps by Application - Percentage Breakdown of Value Sales for Pain Application, Spasticity Application, Cardiovascular Application and Other Applications for the Years 2025 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Smart Implantable Pumps by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Europe 6-Year Perspective for Smart Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • FRANCE
    • Smart Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 54: France Recent Past, Current & Future Analysis for Smart Implantable Pumps by Pump Type - Smart Perfusion Pumps and Smart Micro Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: France 6-Year Perspective for Smart Implantable Pumps by Pump Type - Percentage Breakdown of Value Sales for Smart Perfusion Pumps and Smart Micro Pumps for the Years 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Smart Implantable Pumps by Application - Pain Application, Spasticity Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France 6-Year Perspective for Smart Implantable Pumps by Application - Percentage Breakdown of Value Sales for Pain Application, Spasticity Application, Cardiovascular Application and Other Applications for the Years 2025 & 2030
    • TABLE 58: France Recent Past, Current & Future Analysis for Smart Implantable Pumps by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: France 6-Year Perspective for Smart Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • GERMANY
    • Smart Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 60: Germany Recent Past, Current & Future Analysis for Smart Implantable Pumps by Pump Type - Smart Perfusion Pumps and Smart Micro Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Germany 6-Year Perspective for Smart Implantable Pumps by Pump Type - Percentage Breakdown of Value Sales for Smart Perfusion Pumps and Smart Micro Pumps for the Years 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Smart Implantable Pumps by Application - Pain Application, Spasticity Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany 6-Year Perspective for Smart Implantable Pumps by Application - Percentage Breakdown of Value Sales for Pain Application, Spasticity Application, Cardiovascular Application and Other Applications for the Years 2025 & 2030
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Smart Implantable Pumps by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Germany 6-Year Perspective for Smart Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • ITALY
    • TABLE 66: Italy Recent Past, Current & Future Analysis for Smart Implantable Pumps by Pump Type - Smart Perfusion Pumps and Smart Micro Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Italy 6-Year Perspective for Smart Implantable Pumps by Pump Type - Percentage Breakdown of Value Sales for Smart Perfusion Pumps and Smart Micro Pumps for the Years 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Smart Implantable Pumps by Application - Pain Application, Spasticity Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy 6-Year Perspective for Smart Implantable Pumps by Application - Percentage Breakdown of Value Sales for Pain Application, Spasticity Application, Cardiovascular Application and Other Applications for the Years 2025 & 2030
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Smart Implantable Pumps by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Italy 6-Year Perspective for Smart Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • UNITED KINGDOM
    • Smart Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 72: UK Recent Past, Current & Future Analysis for Smart Implantable Pumps by Pump Type - Smart Perfusion Pumps and Smart Micro Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: UK 6-Year Perspective for Smart Implantable Pumps by Pump Type - Percentage Breakdown of Value Sales for Smart Perfusion Pumps and Smart Micro Pumps for the Years 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Smart Implantable Pumps by Application - Pain Application, Spasticity Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK 6-Year Perspective for Smart Implantable Pumps by Application - Percentage Breakdown of Value Sales for Pain Application, Spasticity Application, Cardiovascular Application and Other Applications for the Years 2025 & 2030
    • TABLE 76: UK Recent Past, Current & Future Analysis for Smart Implantable Pumps by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 77: UK 6-Year Perspective for Smart Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Smart Implantable Pumps by Pump Type - Smart Perfusion Pumps and Smart Micro Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Rest of Europe 6-Year Perspective for Smart Implantable Pumps by Pump Type - Percentage Breakdown of Value Sales for Smart Perfusion Pumps and Smart Micro Pumps for the Years 2025 & 2030
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Smart Implantable Pumps by Application - Pain Application, Spasticity Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Rest of Europe 6-Year Perspective for Smart Implantable Pumps by Application - Percentage Breakdown of Value Sales for Pain Application, Spasticity Application, Cardiovascular Application and Other Applications for the Years 2025 & 2030
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Smart Implantable Pumps by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 6-Year Perspective for Smart Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Smart Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Smart Implantable Pumps by Pump Type - Smart Perfusion Pumps and Smart Micro Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Asia-Pacific 6-Year Perspective for Smart Implantable Pumps by Pump Type - Percentage Breakdown of Value Sales for Smart Perfusion Pumps and Smart Micro Pumps for the Years 2025 & 2030
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Smart Implantable Pumps by Application - Pain Application, Spasticity Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific 6-Year Perspective for Smart Implantable Pumps by Application - Percentage Breakdown of Value Sales for Pain Application, Spasticity Application, Cardiovascular Application and Other Applications for the Years 2025 & 2030
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Smart Implantable Pumps by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 6-Year Perspective for Smart Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 90: Rest of World Recent Past, Current & Future Analysis for Smart Implantable Pumps by Pump Type - Smart Perfusion Pumps and Smart Micro Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Rest of World 6-Year Perspective for Smart Implantable Pumps by Pump Type - Percentage Breakdown of Value Sales for Smart Perfusion Pumps and Smart Micro Pumps for the Years 2025 & 2030
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Smart Implantable Pumps by Application - Pain Application, Spasticity Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of World 6-Year Perspective for Smart Implantable Pumps by Application - Percentage Breakdown of Value Sales for Pain Application, Spasticity Application, Cardiovascular Application and Other Applications for the Years 2025 & 2030
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Smart Implantable Pumps by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Rest of World 6-Year Perspective for Smart Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2025 & 2030

IV. COMPETITION